For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Healing & Recovery

GHK-Cu + KPV + MOTS-c

Also known as: GHK-Cu/KPV/MOTS-C, Copper peptide + KPV + MOTS-c blend

Research use only · not FDA-approved

Pre-mixed three-peptide blend combining GHK-Cu, KPV, and MOTS-c. GHK-Cu is the copper-binding tripeptide glycyl-L-histidyl-L-lysine, studied for collagen synthesis, wound healing, and antioxidant signaling. KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH and acts as an anti-inflammatory via NF-kB inhibition without melanocortin-receptor activation. MOTS-c is a 16-residue mitochondrial-derived peptide that activates AMPK and is studied for metabolic and exercise-mimetic effects. None of the three is FDA-approved as an injectable therapeutic, and there is no controlled human efficacy or safety data for this specific combination — the rationale is inferred from the individual research compounds.

Where to buy · live market data

Who's worth your money for GHK-Cu + KPV + MOTS-c

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

No sellers for GHK-Cu + KPV + MOTS-c are indexed yet — we add vendors and their prices as we find them.

Watch GHK-Cu + KPV + MOTS-c

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About GHK-Cu + KPV + MOTS-c

CAS

Molecular formula

Typical dose range

Vendor-dependent; GHK-Cu ~1-2 mg, KPV 200-500 mcg, MOTS-c 5-10 mg per dose in research contexts. No validated combination dosing exists.

Half-life

Each component has a short, poorly characterized systemic half-life in humans; no combination pharmacokinetic data.

Common research uses

recovery, anti-inflammatory, and tissue-repair support (research only)skin and collagen support (research only)metabolic and mitochondrial support (research only)

Safety notes

Not FDA-approved; sold as a research-only / grey-market blend. No combination-specific human safety data. Excess parenteral copper exposure is a theoretical concern. Not evaluated by WADA as a blend.

Reconstitution

Reconstitute lyophilized powder with bacteriostatic water; refrigerate after reconstitution.

Independent evidence

COAs for GHK-Cu + KPV + MOTS-c

1 third-party test across 1 vendor. Each card links to the full report.

All 1 COAs for GHK-Cu + KPV + MOTS-c →
Measured purity over time

Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.